TKN
Alpha Teknova
Stock
Stock
Ticker: TKNO
TKNO
Price
Price
CHART BY
Frequently asked questions
What is Alpha Teknova's market capitalization?
The market capitalization of Alpha Teknova is $408.03M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Alpha Teknova?
Alpha Teknova's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.313. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Alpha Teknova's stock?
Currently, 8 analysts cover Alpha Teknova's stock, with a consensus target price of $9.667. Analyst ratings provide insights into the stock's expected performance.
What is Alpha Teknova's revenue over the trailing twelve months?
Over the trailing twelve months, Alpha Teknova reported a revenue of $43.70M.
What is the EBITDA for Alpha Teknova?
Alpha Teknova's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$8.99M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Alpha Teknova?
Alpha Teknova has a free cash flow of -$7.35M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Alpha Teknova have, and what sector and industry does it belong to?
Alpha Teknova employs approximately 158 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Alpha Teknova's shares?
The free float of Alpha Teknova is 10.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $408.03M
- EPS (TTM)
- -$0.313
- Free Float
- 10.93M
- Revenue (TTM)
- $43.70M
- EBITDA (TTM)
- -$8.99M
- Free Cashflow (TTM)
- -$7.35M
Pricing
- 52W span
- $1.91$9.44
Analyst Ratings
The price target is $9.667 and the stock is covered by 8 analysts.
Buy
7
Hold
1
Sell
0
Information
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
- Employees
- 158
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- TKNO
Fundamentals & EOD data from FactSet